Are the randomized trials of radiation therapy for ductal carcinoma in situ still relevant?

Journal of Clinical Oncology

Volumn 32, Issue 32, 2014, Pages 3588-3590

  Recht, Abram ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURGERY; DISEASE FREE SURVIVAL; EDITORIAL; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; PROCEDURES; SEGMENTAL MASTECTOMY;

BREAST NEOPLASMS; CARCINOMA IN SITU; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL;

EID: 84911483504     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.1066     Document Type: Editorial

References (45)

1. Wärnberg F, Garmo H, Emdin S, et al: Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: Twenty-year follow-up in the randomized SweDCIS trial. J Clin Oncol 32:3613-3618, 2014
2. Wapnir IL, Dignam JJ, Fisher B, et al: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478-488, 2011
3. Donker M, Litière S, Werutsky G, et al: Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054-4059, 2013
4. Cuzick J, Sestak I, Pinder SE, et al: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21-29, 2011
5. Early Breast Cancer Trialists' Collaborative Group, Correa C, McGale P, et al: Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162-177, 2010
6. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: Intraductal carcinoma (ductal carcinoma in situ)-The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 75:1310-1319, 1995
7. Arnesson L-G, Smeds S, Fagerberg G, et al: Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br J Surg 76:672-675, 1989
8. Waheda Y, Sibbering DM, Pinder SE, et al: Local excision with a 10 mm margin as sole treatment for DCIS of the breast. Eur J Surg Oncol 24:629, 1998 (abstr)
9. Hetelekidis S, Collins L, Silver B, et al: Predictors of local recurrence following excision alone for ductal carcinoma in situ. Cancer 85:427-431, 1999
10. Silverstein MJ, Lagios MD, Groshen S, et al: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455-1461, 1999
11. Chan KC, Knox WF, Sinha G, et al: Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 91:9-16, 2001
12. Lagios MD, Margolin FR, Westdahl PR, et al: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 63:618-624, 1989
13. Page DL, Lagios MD: Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast. Cancer Lett 86:1-4, 1994
14. Silverstein MJ, Poller DN, Waisman JR, et al: Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154-1157, 1995
15. Silverstein MJ, Lagios MD, Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267-2274, 1996
16. Silverstein MJ, Lagios MD: Choosing treatment for patients with ductal carcinoma in situ: Fine tuning the University of Southern California/Van Nuys Prognostic Index. J Natl Cancer Inst Monogr 2010:193-196, 2010
17. Di Saverio S, Catena F, Santini D, et al: 259 patients with DCIS of the breast applying USC/Van Nuys prognostic index: A retrospective review with long term follow up. Breast Cancer Res Treat 109:405-416, 2008
18. Rudloff U, Jacks LM, Goldberg JI, et al: Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762-3769, 2010
19. Yi M, Meric-Bernstam F, Kuerer HM, et al: Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 30:600-607, 2012
20. Wong JS, Kaelin CM, Troyan SL, et al: Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24:1031-1036, 2006
21. Wong JS, Chen YH, Gadd MA, et al: Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 143:343-350, 2014
22. Allred DC, Wu Y, Mao S, et al: Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14:370-378, 2008
23. Park SY, Gönen M, Kim HJ, et al: Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 120:636-644, 2010
24. Cowell CF, Weigelt B, Sakr RA, et al: Progression from ductal carcinoma in situ to invasive breast cancer: Revisited. Mol Oncol 7:859-869, 2013
25. Hughes LL, Wang M, Page DL, et al: Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319-5324, 2009
26. Solin LJ, Gray R, Baehner FL, et al: A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 105:701-710, 2013
27. McCormick B: RTOG 9804: A prospective randomized trial for "good risk" ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS). J Clin Oncol 30:50s, 2012 (suppl; abstract 1004)
28. McCormick B, Moughan J, Hudis C, et al: Low-risk breast ductal carcinoma in situ (DCIS): Results from the Radiation Therapy Oncology Group 9804 phase 3 trial. Int J Radiat Oncol Biol Phys 84, 2012 (suppl; abstr 11)
29. Halasz LM, Sreedhara M, Chen YH, et al: Improved outcomes of breastconserving therapy for patients with ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 82:82e-581e, 2012
30. Wong P, Lambert C, Agnihotram RV, et al: Ductal carcinoma in situ: The influence of the radiotherapy boost on local control. Int J Radiat Oncol Biol Phys 82:82e-153e, 2012
31. Allred DC, Anderson SJ, Paik S, et al: Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: A study based on NSABP protocol B-24. J Clin Oncol 30:1268-1273, 2012
32. Bartlett JM, Nofech-Moses S, Rakovitch E: Ductal carcinoma in situ of the breast: Can biomarkers improve current management? Clin Chem 60:60-67, 2014
33. Lazzeroni M, Guerrieri-Gonzaga A, Botteri E, et al: Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype. Br J Cancer 108:1593-1601, 2013
34. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998
35. Greenberg CC, Habel LA, Hughes ME, et al: Characterization and treatment of local recurrence following breast conservation for ductal carcinoma in situ. Ann Surg Oncol [epub online ahead of print on May 24, 2014]
36. Solin LJ, Fourquet A, Vicini FA, et al: Long-term outcome after breastconservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103:1137-1146, 2005
37. Wai ES, Lesperance ML, Alexander CS, et al: Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone. Ann Surg Oncol 18:119-124, 2011
38. Wallis MG, Clements K, Kearins O, et al: The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. Br J Cancer 106:1611-1617, 2012
39. Early Breast Cancer Trialists' Collaborative Group, Darby S, McGale P, et al: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10, 801 women in 17 randomised trials. Lancet 378:1707-1716, 2011
40. Bombonati A, Sgroi DC: The molecular pathology of breast cancer progression. J Pathol 223:307-317, 2011
41. Knudsen ES, Ertel A, Davicioni E, et al: Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. Breast Cancer Res Treat 133:1009-1024, 2012
42. Shapiro CL, Recht A: Side effects of adjuvant therapy for breast cancer. N Engl J Med 344:1997-2008, 2001
43. Wehner P, Lagios MD, Silverstein MJ: DCIS treated with excision alone using the National Comprehensive Cancer Network (NCCN) guidelines. Ann Surg Oncol 20:3175-3179, 2013
44. Partridge A, Adloff K, Blood E, et al: Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: Longitudinal results from a cohort study. J Natl Cancer Inst 100:243-251, 2008
45. Partridge AH, Elmore JG, Saslow D, et al: Challenges in ductal carcinoma in situ risk communication and decision-making: Report from an American Cancer Society and National Cancer Institute workshop. CA Cancer J Clin 62:203-210, 2012